K.J. Psoter, A.J. De Roos, J. Wakefield, J. Mayer, M. Rosenfeld

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Evolution of the incidence of hepatitis B virus infection and immunization rates in a large French cohort born between 1960 and 1994 C. Ramière, L. Roche,

Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients R. Cantón, N. Cobos,

Gut bacterial microbiota and obesity

M.F.Q. Kluytmans-VandenBergh, J.A.J.W. Kluytmans

Approach to diagnosis of infective endocarditis

Incidence and outcome of Staphylococcus aureus endocarditis—a 10-year single-centre northern European experience H. Asgeirsson, A. Thalme, M. Kristjansson,

Economic evaluation of vaccination: capturing the full benefits, with an application to human papillomavirus T. Bärnighausen, D.E. Bloom, E.T. Cafiero,

Molecular characterization of methicillin-resistant Staphylococcus aureus isolated over a 2-year period in a Qatari hospital from multinational patients

D. Khalil, M. Hultin, M.U. Rashid, B. Lund

Herpes zoster in non-hospitalized children

Migrant health—a cause for concern?

Type 3 secretion system effector genotype and secretion phenotype of longitudinally collected Pseudomonas aeruginosa isolates from young children diagnosed.

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Cost-effectiveness of universal MRSA screening on admission to surgery

R. Cantón Clinical Microbiology and Infection

Louis Pasteur, from crystals of life to vaccination

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

J. Cairo, R. Hachem, G. Rangaraj, B. Granwehr, I. Raad

Revision of linezolid disk diffusion quality control guidelines for testing Staphylococcus aureus ATCC 25923: an independent seven-laboratory trial D.J.

How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach D. Guillemot Clinical Microbiology.

Vector control: a cornerstone in the malaria elimination campaign

A longitudinal analysis of chronic MRSA and Pseudomonas aeruginosa co-infection in cystic fibrosis: A single-center study Maret L. Maliniak, Arlene A.

A. Oliver, A. Mena Clinical Microbiology and Infection

Training for the infectious diseases speciality in Norway

Laboratory diagnosis and biosafety issues of biological warfare agents

Bacterial resistance—the clinical challenge

Strategies for managing today's infections

G. Kronvall Clinical Microbiology and Infection

André Bryskier Clinical Microbiology and Infection

In vitro selection of antibiotic resistance in Pseudomonas aeruginosa

Metagenomics and probiotics

M. Aires-de-Sousa Clinical Microbiology and Infection

M. C. Alanin, K. G. Nielsen, C. von Buchwald, M. Skov, K. Aanaes, N

U. Sagel, R.T. Mikolajczyk, A. Krämer

Laboratory diagnosis of Clostridium difficile disease

Systematic review of antibiotic consumption in acute care hospitals

Increasing incidence but decreasing in-hospital mortality of adult Staphylococcus aureus bacteraemia between 1981 and 2000 T. Benfield, F. Espersen,

Combination antimicrobial therapy in patients with Staphylococcus aureus bacteraemia—a post hoc analysis in 964 prospectively evaluated patients S. Rieg,

Antibacterial drug discovery in the 21st century

Community-acquired pneumonia: epidemiologic and clinical consideration

P.M. Hawkey Clinical Microbiology and Infection

Gender differences in the outcome of community-acquired Staphylococcus aureus bacteraemia: a historical population-based cohort study J. Smit, L.E. López-Cortés,

Sequential time to positivity of blood cultures can be a predictor of prognosis of patients with persistent Staphylococcus aureus bacteraemia M.-S. Hsu,

G.M. Rossolini, E. Mantengoli Clinical Microbiology and Infection

Statin use and clinical outcomes among pneumonia patients

Clinical Microbiology and Infection

Clinical Microbiology and Infection

Rise and subsequent decline of community-associated methicillin resistant Staphylococcus aureus ST30-IVc in Copenhagen, Denmark through an effective search.

Real-time comparative monitoring of the A/H1N1 pandemic in France

V. Thompson, N. Mayer-Hamblett, M. Kloster, D. Bilton, P.A. Flume

K. Kaier, N.T. Mutters, U. Frank Clinical Microbiology and Infection

The atypical pneumonias: clinical diagnosis and importance

Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe Robert D. Fox Clinical Microbiology.

Abstracts Clinical Microbiology and Infection

Modelling during an emergency: the 2009 H1N1 influenza pandemic

New oral cephalosporins in pediatric community-acquired infections

A. Manzur, F. Gudiol Clinical Microbiology and Infection

Are we losing the fight against malaria one more time?

B.A. Cunha Clinical Microbiology and Infection

Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group† H. Goossens Clinical.

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

D.A. Robinson, M.C. Enright Clinical Microbiology and Infection

Impact of antibiotic restrictions: the patient's perspective

B. Martha, D. Croisier, A. Fanton, K. Astruc, L. Piroth, F. Huet, P

CMI readers' survey Clinical Microbiology and Infection

The future of diagnostic bacteriology

Presentation transcript:

Season is associated with Pseudomonas aeruginosa acquisition in young children with cystic fibrosis K.J. Psoter, A.J. De Roos, J. Wakefield, J. Mayer, M. Rosenfeld Clinical Microbiology and Infection Volume 19, Issue 11, Pages E483-E489 (November 2013) DOI: 10.1111/1469-0691.12272 Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 1 Climate zones of the continental USA based on the revised Koppen–Geiger climate classification (adapted from Peel et al. [16]). Clinical Microbiology and Infection 2013 19, E483-E489DOI: (10.1111/1469-0691.12272) Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 2 Flow chart of study cohort for evaluation of acquisition of Pseudomonas aeruginosa (Pa). [This figure was corrected on 04/07/2013, after original online publication 25/06/2013. In the bottom right hand box “Acquired Pa during follow-up”, “n = 2265'’ has been corrected to “n = 1866”.] Clinical Microbiology and Infection 2013 19, E483-E489DOI: (10.1111/1469-0691.12272) Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 3 Seasonal incidence rates for Pseudomonas aeruginosa acquisition among young children with cystic fibrosis in the USA from 2003 to 2009. Whiskers represent 95% confidence intervals. Clinical Microbiology and Infection 2013 19, E483-E489DOI: (10.1111/1469-0691.12272) Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 4 Seasonal incidence rates for Staphylococcus aureus acquisition among young children with cystic fibrosis in the USA from 2003 to 2009. Whiskers represent 95% confidence intervals. Clinical Microbiology and Infection 2013 19, E483-E489DOI: (10.1111/1469-0691.12272) Copyright © 2013 European Society of Clinical Infectious Diseases Terms and Conditions